Literature DB >> 22751000

Omission of day-11 MTX, in combination with tacrolimus, is not associated with increased risk of acute graft-versus-host disease after allo-BMT.

A Honda, K Kakihana, J Aoki, T Kobayashi, N Doki, H Sakamaki, K Ohashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22751000     DOI： 10.1038/bmt.2012.128

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  1 in total

1.  Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study.

Authors:  B K Hamilton; L Rybicki; H Haddad; D Abounader; M Yurch; N S Majhail; R Hanna; R Sobecks; R Dean; H Liu; B Hill; E Copelan; B Bolwell; M Kalaycio
Journal:  Blood Cancer J       Date:  2015-08-28       Impact factor: 11.037
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.